After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Xilio Therapeutics Inc is $40.43M. A total of 0.54 million shares were traded on the day, compared to an average of 568.53K shares.
In the most recent transaction, Shannon James Samuel bought 45,000 shares of XLO for 0.69 per share on Jun 16 ’25. After the transaction, the Director now owns 45,000 company shares. In a previous transaction on Jun 17 ’25, Shannon James Samuel bought 25,000 shares at 0.69 per share. XLO shares that Director owns now total 70,000.
Among the insiders who bought shares, Russo Rene acquired of 36,289 shares on Jun 16 ’25 at a per-share price of $0.68. This resulted in the PRESIDENT AND CEO holding 281,172 shares of XLO after the transaction. In another insider transaction, Frankenfield Christopher James sold 6,954 shares at $0.98 per share on Jan 02 ’25. Company shares held by the Chief Financial Officer now total 12,421.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, XLO has a high of $1.70 and a low of $0.62.
As of this writing, XLO has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $0.02 per share and a lower estimate of -$0.08. The company reported an EPS of -$0.22 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. XLO’s latest balance sheet shows that the firm has $198.05M in Cash & Short Term Investments as of fiscal 2021. There were $20.54M in debt and $12.78M in liabilities at the time. Its Book Value Per Share was $0.14, while its Total Shareholder’s Equity was $185.43M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock.
